The 71 DKTK Munich Cancer Colloquium will be held on March 23, 2026.
Agenda
Leveraging real-world data for knowledge generation in patients receiving T-cell based immunotherapies PD Dr. med. Kai Rejeski, MHBA Group Leader Precision Immunotherapy, Department of Internal Medicine III, LMU Klinikum
Uncovering orchestrators of immunosuppression in pancreatic cancer using spatial functional genomics Chiara Falcomatà, PhD Postdoctoral fellow at Brown Lab at Icahn School of Medicine at Mount Sinai; New York, USA
